Ulinastatin, a human protease inhibitor and androstenediol, a metabolite of dihydroxystheniandrosterone, reduce plasma levels of TNF-α and IL-6 in rats with sepsis [60,61]. This evidence concerns the gene IL6 and Sepsis.